to edit and comment
a collaborative knowledge base characterizing the state of current thought in Cognitive Science.

Three overarching ADNI goals are:


- To detect Alzheimer’s disease (AD) at the earliest stage possible and identify ways to track the disease through biomarkers.

- To support advances in AD intervention, prevention and treatment through the application of new diagnostic methods to apply at the earliest stages technically possible - when intervention may be most effective.

- To continually develop ADNI’s now- legendary data access policy and continuously improve and expand the unprecedented data sharing model.


ADNI began in October 2004 and was designed to find more sensitive and accurate methods to detect Alzheimer’s disease at earlier stages and mark its progress through biomarkers. The study gathered and analyzed thousands of brain scans, genetic profiles, and biomarkers in blood and cerebrospinal fluid that are used to measure the progress of disease or the effects of treatment.



Definition contributed by Anonymous
INDICATORS

No indicators have yet been associated.

An indicator is a specific quantitative or qualitative variable that is recorded for analysis. These may include behavioral variables (such as response time, accuracy, or other measures of performance) or physiological variables (including genetics, psychophysiology, or brain imaging data).

Term BIBLIOGRAPHY

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L
Alzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement)
2005 Jul